Company
Ray Therapeutics
| Industry | clinical-stage biopharmaceutical company developing differentiated vision restoration therapies for those living with retinal degenerations |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Ray Therapeutics | Series B | 2026-04-21 |
| Ray Therapeutics | Series A Financing | 2023-05-16 |